Table 1.

Demographic and clinical characteristics of included patients

Age (years), mean (range)	62.4 (48–82)
Gender (M/F), n	42/15
Etiology, n
HBV	52
HCV	3
Others	2
Child-Pugh class (A/B), n	52/5
Tumor size (cm), mean (range)	2.4 (0.6–4.0)
Tumor location, n (%)
Near diaphragm or liver dome	18 (26.5)
Near stomach or bowel	9 (13.2)
Near body wall	33 (48.5)
Near kidney	8 (11.8)
Cryoablation as primary therapy, n (%)	29 (42.6)
After TACE, n (%)	23 (33.8)
After RFA, n (%)	7 (10.3)
After TACE+RFA, n (%)	9 (13.2)

M, male; F, female; HBV, hepatitis B virus; HCV, hepatitis C virus; TACE, transarterial chemoembolization; RFA, radiofrequency ablation.